메뉴 건너뛰기




Volumn 48, Issue 12, 1999, Pages 1524-1531

Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ACUTE PHASE PROTEIN; ALPHA INTERFERON; ANTIRETROVIRUS AGENT; HIGH DENSITY LIPOPROTEIN; LAMIVUDINE; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; THROMBOCYTE ACTIVATING FACTOR;

EID: 0032739886     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90240-8     Document Type: Article
Times cited : (35)

References (51)
  • 1
    • 0022555858 scopus 로고
    • Platelet-activating factor: A biological active phosphoglyceride
    • Hanahan DJ: Platelet-activating factor: A biological active phosphoglyceride. Annu Rev Biochem 55:483-509, 1986
    • (1986) Annu Rev Biochem , vol.55 , pp. 483-509
    • Hanahan, D.J.1
  • 2
    • 0027723521 scopus 로고
    • PAF molecular heterogeneity: Pathobiological implications
    • McManus LM, Woodard DS, Deavers SI, et al: PAF molecular heterogeneity: Pathobiological implications. Lab Invest 69:639-650, 1993
    • (1993) Lab Invest , vol.69 , pp. 639-650
    • McManus, L.M.1    Woodard, D.S.2    Deavers, S.I.3
  • 3
    • 0028998204 scopus 로고
    • Platelet-activating factor: A mediator for clinicians
    • Imaizumi T, Stafforini DM, Yamada Y, et al: Platelet-activating factor: A mediator for clinicians. J Intern Med 238:5-20, 1995
    • (1995) J Intern Med , vol.238 , pp. 5-20
    • Imaizumi, T.1    Stafforini, D.M.2    Yamada, Y.3
  • 5
    • 0023278621 scopus 로고
    • Human plateletactivating factor acetylhydrolase: Association with lipoprotein particles and role in the degradation of platelet-activating factor
    • Stafforini DM, McIntyre TM, Carter E, et al: Human plateletactivating factor acetylhydrolase: Association with lipoprotein particles and role in the degradation of platelet-activating factor. J Biol Chem 262:4215-4222, 1987
    • (1987) J Biol Chem , vol.262 , pp. 4215-4222
    • Stafforini, D.M.1    McIntyre, T.M.2    Carter, E.3
  • 6
    • 0023180687 scopus 로고
    • Human plasma platelet-activating factor acetylhydrolase: Purification and properties
    • Stafforini DM, Prescott SM, McIntyre TM: Human plasma platelet-activating factor acetylhydrolase: Purification and properties. J Biol Chem 262:4223-4230, 1987
    • (1987) J Biol Chem , vol.262 , pp. 4223-4230
    • Stafforini, D.M.1    Prescott, S.M.2    McIntyre, T.M.3
  • 7
    • 0024269780 scopus 로고
    • Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion
    • Lewis MS, Whatley RE, Cain P, et al: Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. J Clin Invest 82:2045-2055, 1988
    • (1988) J Clin Invest , vol.82 , pp. 2045-2055
    • Lewis, M.S.1    Whatley, R.E.2    Cain, P.3
  • 8
    • 0025864391 scopus 로고
    • 3H]acetyl-sn-glycero-3-phosphocholine, a structural analog of plateletactivating factor, by vascular endothelial cells
    • 3H]acetyl-sn-glycero-3-phosphocholine, a structural analog of plateletactivating factor, by vascular endothelial cells. Biochem Biophys Res Commun 176:1557-1564, 1991
    • (1991) Biochem Biophys Res Commun , vol.176 , pp. 1557-1564
    • Mueller, H.W.1    Nollert, M.U.2    Eskin, S.G.3
  • 9
    • 0026032592 scopus 로고
    • Platelet-activating factor (PAF) stimulates the production of PAF acetylhydrolase by the human hepatoma cell line, HepG2
    • Satoh K, Imaizumi T, Kawamura Y, et al: Platelet-activating factor (PAF) stimulates the production of PAF acetylhydrolase by the human hepatoma cell line, HepG2. J Clin Invest 87:476-481, 1991
    • (1991) J Clin Invest , vol.87 , pp. 476-481
    • Satoh, K.1    Imaizumi, T.2    Kawamura, Y.3
  • 10
    • 0030728103 scopus 로고    scopus 로고
    • Platelet-activating factor (PAF) up-regulates plasma and tissue PAF-acetylhydrolase activity in the rat: Effect of cycloheximide
    • Wang H, Tan X, Qu X, et al: Platelet-activating factor (PAF) up-regulates plasma and tissue PAF-acetylhydrolase activity in the rat: Effect of cycloheximide. Pediatr Res 42:597-603, 1997
    • (1997) Pediatr Res , vol.42 , pp. 597-603
    • Wang, H.1    Tan, X.2    Qu, X.3
  • 11
    • 0024536159 scopus 로고
    • An oxidized derivative of phosphatidylcholine is a substrate for the plateletactivating factor acetylhydrolase from human plasma
    • Stremler KE, Stafforini DM, Prescott SM, et al: An oxidized derivative of phosphatidylcholine is a substrate for the plateletactivating factor acetylhydrolase from human plasma. J Biol Chem 264:5331-5334, 1989
    • (1989) J Biol Chem , vol.264 , pp. 5331-5334
    • Stremler, K.E.1    Stafforini, D.M.2    Prescott, S.M.3
  • 12
    • 0025908558 scopus 로고
    • Human plasma platelet-activating factor acetylhydrolase: Oxidatively fragmented phospholipids as substrates
    • Stremler KE, Stafforini DM, Prescott SM, et al: Human plasma platelet-activating factor acetylhydrolase: Oxidatively fragmented phospholipids as substrates. J Biol Chem 266:11095-11103, 1991
    • (1991) J Biol Chem , vol.266 , pp. 11095-11103
    • Stremler, K.E.1    Stafforini, D.M.2    Prescott, S.M.3
  • 13
    • 0027027667 scopus 로고
    • The platelet-activating factor acetylhydrolase from human plasma prevents oxidative modification of low density lipoprotein
    • Stafforini DM, Zimmerman GA, McIntyre TM, et al: The platelet-activating factor acetylhydrolase from human plasma prevents oxidative modification of low density lipoprotein. Trans Assoc Am Phys 105:44-63, 1992
    • (1992) Trans Assoc Am Phys , vol.105 , pp. 44-63
    • Stafforini, D.M.1    Zimmerman, G.A.2    McIntyre, T.M.3
  • 14
    • 0027501249 scopus 로고
    • Effects of endotoxins and cytokines on the secretion of platelet-activating factor-acetylhydrolase by human decidual macrophages
    • Narahara H, Johnston JM: Effects of endotoxins and cytokines on the secretion of platelet-activating factor-acetylhydrolase by human decidual macrophages. Am J Obstet Gynecol 169:531-537, 1993
    • (1993) Am J Obstet Gynecol , vol.169 , pp. 531-537
    • Narahara, H.1    Johnston, J.M.2
  • 15
    • 0028968049 scopus 로고
    • Anti-inflammatory properties of a platelet-activating factor acetylhydrolase
    • Tjoelker LW, Wilder C, Eberhardt C, et al: Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature 374:549-553, 1995
    • (1995) Nature , vol.374 , pp. 549-553
    • Tjoelker, L.W.1    Wilder, C.2    Eberhardt, C.3
  • 16
    • 0030786198 scopus 로고    scopus 로고
    • Cell-specific regulation of expression of plasma-type platelet-activating factor acetylhydrolase in the liver
    • Howard KM, Miller JE, Miwa M, et al: Cell-specific regulation of expression of plasma-type platelet-activating factor acetylhydrolase in the liver. J Biol Chem 272:27543-27548, 1997
    • (1997) J Biol Chem , vol.272 , pp. 27543-27548
    • Howard, K.M.1    Miller, J.E.2    Miwa, M.3
  • 17
    • 0028859490 scopus 로고
    • Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response: Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures
    • Van Lenten BJ, Hama SY, de Beer FC, et al: Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response: Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest 96:2758-2767, 1995
    • (1995) J Clin Invest , vol.96 , pp. 2758-2767
    • Van Lenten, B.J.1    Hama, S.Y.2    De Beer, F.C.3
  • 18
    • 0032765305 scopus 로고    scopus 로고
    • In vivo regulation of plasma platelet-activating factor acetylhydrolase activity and mRNA expression during the acute phase response
    • Memon RA, Fuller J, Moser AH, et al: In vivo regulation of plasma platelet-activating factor acetylhydrolase activity and mRNA expression during the acute phase response. Am J Physiol 277(1 pt 2):R94-R103, 1999
    • (1999) Am J Physiol , vol.277 , Issue.1 PART 2
    • Memon, R.A.1    Fuller, J.2    Moser, A.H.3
  • 19
    • 0029876932 scopus 로고    scopus 로고
    • Platelet-activating factor levels and PAF acetylhydrolase activities in patients with primary glomerulonephritis
    • Iatrou C, Moustakas G, Antonopoulos S, et al: Platelet-activating factor levels and PAF acetylhydrolase activities in patients with primary glomerulonephritis. Nephron 72:611-616, 1996
    • (1996) Nephron , vol.72 , pp. 611-616
    • Iatrou, C.1    Moustakas, G.2    Antonopoulos, S.3
  • 20
    • 0026802165 scopus 로고
    • Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases
    • Dulioust A, Hilliquin P, Menkes CJ, et al: Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases. Scand J Rheumatol 21:161-164, 1992
    • (1992) Scand J Rheumatol , vol.21 , pp. 161-164
    • Dulioust, A.1    Hilliquin, P.2    Menkes, C.J.3
  • 21
    • 0028029156 scopus 로고
    • Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis
    • Graham RM, Stephens CJ, Silvester W, et al: Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis. Crit Care Med 22:204-212, 1994
    • (1994) Crit Care Med , vol.22 , pp. 204-212
    • Graham, R.M.1    Stephens, C.J.2    Silvester, W.3
  • 22
    • 0028178445 scopus 로고
    • Platelet-activating factor (PAF) acetylhydrolase activity, type II phospholipase A2, and cytokine levels in patients with sepsis
    • Endo S, Inada K, Yamashita H, et al: Platelet-activating factor (PAF) acetylhydrolase activity, type II phospholipase A2, and cytokine levels in patients with sepsis. Res Commun Mol Pathol Pharmacol 83:289-295, 1994
    • (1994) Res Commun Mol Pathol Pharmacol , vol.83 , pp. 289-295
    • Endo, S.1    Inada, K.2    Yamashita, H.3
  • 23
    • 0024205844 scopus 로고
    • The degradation of platelet-activating factor in serum and its discriminative value in atherosclerotic patients
    • Ostermann G, Lang A, Holtz H, et al: The degradation of platelet-activating factor in serum and its discriminative value in atherosclerotic patients. Thromb Res 52:529-540, 1988
    • (1988) Thromb Res , vol.52 , pp. 529-540
    • Ostermann, G.1    Lang, A.2    Holtz, H.3
  • 24
    • 0023251376 scopus 로고
    • Plasma from atherosclerotic patients exerts an increased degradation of plateletactivating factor
    • Ostermann G, Ruhling K, Zabel-Langhennig R, et al: Plasma from atherosclerotic patients exerts an increased degradation of plateletactivating factor. Thromb Res 47:279-285, 1987
    • (1987) Thromb Res , vol.47 , pp. 279-285
    • Ostermann, G.1    Ruhling, K.2    Zabel-Langhennig, R.3
  • 25
    • 0026751255 scopus 로고
    • Platelet-activating factor acetylhydrolase in plasma lipoproteins from patients with ischemic stroke
    • Satoh K, Yoshida H, Imaizumi T, et al: Platelet-activating factor acetylhydrolase in plasma lipoproteins from patients with ischemic stroke. Stroke 23:1090-1092, 1992
    • (1992) Stroke , vol.23 , pp. 1090-1092
    • Satoh, K.1    Yoshida, H.2    Imaizumi, T.3
  • 26
    • 0024357049 scopus 로고
    • Increased activity of the platelet-activating factor acetylhydrolase in plasma low density lipoprotein from patients with essential hypertension
    • Satoh K, Imiazumi T, Kawamura Y, et al: Increased activity of the platelet-activating factor acetylhydrolase in plasma low density lipoprotein from patients with essential hypertension. Prostaglandins 37:673-682, 1989
    • (1989) Prostaglandins , vol.37 , pp. 673-682
    • Satoh, K.1    Imiazumi, T.2    Kawamura, Y.3
  • 27
    • 0030822866 scopus 로고    scopus 로고
    • Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolemia
    • Karabina SAP, Elisaf M, Bairaktari E, et al: Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolemia. Eur J Clin Invest 27:595-602, 1997
    • (1997) Eur J Clin Invest , vol.27 , pp. 595-602
    • Karabina, S.A.P.1    Elisaf, M.2    Bairaktari, E.3
  • 28
    • 0030699106 scopus 로고    scopus 로고
    • Determinants of plasma platelet-activating factor acetylhydrolase: Heritability and relationship to plasma lipoproteins
    • Guerra R, Zhao B, Mooser V, et al: Determinants of plasma platelet-activating factor acetylhydrolase: Heritability and relationship to plasma lipoproteins. J Lipid Res 38:2281-2288, 1997
    • (1997) J Lipid Res , vol.38 , pp. 2281-2288
    • Guerra, R.1    Zhao, B.2    Mooser, V.3
  • 29
    • 0024855170 scopus 로고
    • Blood platelet behaviour in patients with a type 1 diabetes mellitus
    • Spangenberg P, Schymik CH, Hofmann B, et al: Blood platelet behaviour in patients with a type 1 diabetes mellitus. Exp Clin Endocrinol 94:329-337, 1989
    • (1989) Exp Clin Endocrinol , vol.94 , pp. 329-337
    • Spangenberg, P.1    Schymik, C.H.2    Hofmann, B.3
  • 30
    • 0024600767 scopus 로고
    • Enhanced degradation of platelet-activating factor in serum from diabetic patients
    • Hofmann B, Ruhling K, Spangenberg P, et al: Enhanced degradation of platelet-activating factor in serum from diabetic patients. Haemostasis 19:180-184, 1989
    • (1989) Haemostasis , vol.19 , pp. 180-184
    • Hofmann, B.1    Ruhling, K.2    Spangenberg, P.3
  • 31
    • 0025293212 scopus 로고
    • Activity of plateletactivating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokers
    • Imaizumi T, Satoh K, Yoshida H, et al: Activity of plateletactivating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokers. Heart Vessels 5:81-86, 1990
    • (1990) Heart Vessels , vol.5 , pp. 81-86
    • Imaizumi, T.1    Satoh, K.2    Yoshida, H.3
  • 32
    • 0024497306 scopus 로고
    • Hypertriglyceridemia in the acquired immunodeficiency syndrome
    • Grunfeld C, Kotler DP, Hamadeh R, et al: Hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 86:27-31, 1989
    • (1989) Am J Med , vol.86 , pp. 27-31
    • Grunfeld, C.1    Kotler, D.P.2    Hamadeh, R.3
  • 33
    • 0026716993 scopus 로고
    • Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome
    • Grunfeld C, Pang M, Doerrler W, et al: Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 74:1045-1052, 1992
    • (1992) J Clin Endocrinol Metab , vol.74 , pp. 1045-1052
    • Grunfeld, C.1    Pang, M.2    Doerrler, W.3
  • 34
    • 0027167664 scopus 로고
    • The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B
    • Feingold KR, Krauss RM, Pang M, et al: The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B. J Clin Endocrinol Metab 76:1423-1427, 1993
    • (1993) J Clin Endocrinol Metab , vol.76 , pp. 1423-1427
    • Feingold, K.R.1    Krauss, R.M.2    Pang, M.3
  • 35
    • 0027122957 scopus 로고
    • 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS among Adolescents and Adults
    • Centers for Disease Control and Prevention: 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. MMWR 41(No.RR-17):1-13, 1992
    • (1992) MMWR , vol.41 , Issue.RR-17 , pp. 1-13
  • 38
    • 0015348189 scopus 로고
    • Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugation
    • Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugation. Clin Chem 18:499-502, 1972
    • (1972) Clin Chem , vol.18 , pp. 499-502
    • Friedewald, W.T.1    Levy, R.I.2    Fredrickson, D.S.3
  • 39
    • 0030729662 scopus 로고    scopus 로고
    • Evaluation and clinical application of a direct low-density lipoprotein cholesterol assay in normolipidemic and hyperlipidemic adults
    • Yu HH, Ginsburg GS, Harris N, et al: Evaluation and clinical application of a direct low-density lipoprotein cholesterol assay in normolipidemic and hyperlipidemic adults. Am J Cardiol 80:1295-1299, 1997
    • (1997) Am J Cardiol , vol.80 , pp. 1295-1299
    • Yu, H.H.1    Ginsburg, G.S.2    Harris, N.3
  • 40
    • 0025872834 scopus 로고
    • Circulating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndrome
    • Grunfeld C, Kotler DP, Shigenaga JK, et al: Circulating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 90:154-162, 1991
    • (1991) Am J Med , vol.90 , pp. 154-162
    • Grunfeld, C.1    Kotler, D.P.2    Shigenaga, J.K.3
  • 41
    • 0025101682 scopus 로고
    • Genetic heterogeneity of lipoproteins in inbred strains of mice: Analysis by gel-permeation chromatography
    • Jiao S, Cole TG, Kitchens RT, et al: Genetic heterogeneity of lipoproteins in inbred strains of mice: Analysis by gel-permeation chromatography. Metabolism 39:155-160, 1990
    • (1990) Metabolism , vol.39 , pp. 155-160
    • Jiao, S.1    Cole, T.G.2    Kitchens, R.T.3
  • 42
    • 0028225106 scopus 로고
    • Plateletactivating factor: A candidate human immunodeficiency virus type 1-induced neurotoxin
    • Gelbard HA, Nottet HSLM, Swindells S, et al: Plateletactivating factor: A candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol 68:4628-4635, 1994
    • (1994) J Virol , vol.68 , pp. 4628-4635
    • Gelbard, H.A.1    Nottet, H.S.L.M.2    Swindells, S.3
  • 43
    • 0032512846 scopus 로고    scopus 로고
    • Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation
    • Cao Y, Stafforini DM, Zimmerman GA, et al: Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation. J Biol Chem 273:4012-4020, 1998
    • (1998) J Biol Chem , vol.273 , pp. 4012-4020
    • Cao, Y.1    Stafforini, D.M.2    Zimmerman, G.A.3
  • 44
    • 0024384377 scopus 로고
    • Multiple cytokines stimulate hepatic lipid synthesis in vivo
    • Feingold KR, Soued M, Serio MK, et al: Multiple cytokines stimulate hepatic lipid synthesis in vivo. Endocrinology 125:267-274, 1989
    • (1989) Endocrinology , vol.125 , pp. 267-274
    • Feingold, K.R.1    Soued, M.2    Serio, M.K.3
  • 45
    • 0030902788 scopus 로고    scopus 로고
    • Interferon alpha induces disorder of lipid metabolism by lowering postheparin lipases and cholesteryl ester transfer protein activities in patients with chronic hepatitis C
    • Shinohara E, Yamashita S, Kihara S, et al: Interferon alpha induces disorder of lipid metabolism by lowering postheparin lipases and cholesteryl ester transfer protein activities in patients with chronic hepatitis C. Hepatology 25:1502-1506, 1997
    • (1997) Hepatology , vol.25 , pp. 1502-1506
    • Shinohara, E.1    Yamashita, S.2    Kihara, S.3
  • 46
    • 0024603895 scopus 로고
    • Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity
    • Steinberg D, Parthasarathy S, Carew TE, et al: Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924, 1989
    • (1989) N Engl J Med , vol.320 , pp. 915-924
    • Steinberg, D.1    Parthasarathy, S.2    Carew, T.E.3
  • 47
    • 0024439446 scopus 로고
    • Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man
    • Yla-Herttuala S, Palinski W, Rosenfeld ME, et al: Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84:1086-1095, 1989
    • (1989) J Clin Invest , vol.84 , pp. 1086-1095
    • Yla-Herttuala, S.1    Palinski, W.2    Rosenfeld, M.E.3
  • 48
    • 0024521694 scopus 로고
    • Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase
    • Steinbrecher UP, Pritchard PH: Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase. J Lipid Res 30:305-315, 1989
    • (1989) J Lipid Res , vol.30 , pp. 305-315
    • Steinbrecher, U.P.1    Pritchard, P.H.2
  • 49
    • 0001096583 scopus 로고
    • Lysophosphatidylcholine: A chemotactic factor for human monocytes and its potential role in atherogenesis
    • Quinn MT, Parthasarathy S, Steinberg D: Lysophosphatidylcholine: A chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci USA 85:2805-2809, 1988
    • (1988) Proc Natl Acad Sci USA , vol.85 , pp. 2805-2809
    • Quinn, M.T.1    Parthasarathy, S.2    Steinberg, D.3
  • 50
    • 0025286558 scopus 로고
    • Impairment of endothelial-dependent arterial relaxation by lysolecithin in modified low density lipoproteins
    • Kugiyama K, Kerns SA, Morrisett JD, et al: Impairment of endothelial-dependent arterial relaxation by lysolecithin in modified low density lipoproteins. Nature 344:160-162, 1990
    • (1990) Nature , vol.344 , pp. 160-162
    • Kugiyama, K.1    Kerns, S.A.2    Morrisett, J.D.3
  • 51
    • 0028079980 scopus 로고
    • Lysophosphatidylcholine plays an essential role in the mitogenic effects of oxidized low density lipoproteins in murine macrophages
    • Sakai M, Miyazaki A, Hakamata H, et al: Lysophosphatidylcholine plays an essential role in the mitogenic effects of oxidized low density lipoproteins in murine macrophages. J Biol Chem 269:31430-31435, 1994
    • (1994) J Biol Chem , vol.269 , pp. 31430-31435
    • Sakai, M.1    Miyazaki, A.2    Hakamata, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.